T‐cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement
- 1 September 2001
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 114 (3), 624-631
- https://doi.org/10.1046/j.1365-2141.2001.02919.x
Abstract
Nine patients with tumour stage mycosis fungoides (MF) have been entered into a pilot study of T-cell depletion and autologous stem cell transplantation (SCT). Eight patients had detectable rearrangements of the T-cell receptor (TCR) γ-gene demonstrated by polymerase chain reaction (PCR)/single-stranded conformation polymorphism (SSCP) in the peripheral blood. The median age was 47 years and the median duration of disease before SCT was 61 months; Peripheral blood progenitor cells were mobilized using high-dose etoposide (1·6 g/m2) and granulocyte colony-stimulating factor (G-CSF). The apheresis products underwent rigorous T-cell depletion with immunomagnetic methods. Double CD34-positive and CD4/CD8-negative selection achieved a median reduction of 3·89 log of T cells. All nine patients have been transplanted. Conditioning included carmustine (BCNU), etoposide and melphalan (BEM) in seven patients and total body irradiation plus etoposide or melphalan in two. Eight patients engrafted promptly and one patient died of septicaemia. All survivors entered complete remission. Seven patients have relapsed at a median of 7 months (2–14) post SCT. However, most patients have relapsed into a less aggressive stage, which has responded to conventional therapy. Four out of seven evaluable patients had detectable TCR rearrangements in the T-cell depleted graft. A T-cell clone was also detected in the peripheral blood before relapse in four cases. Autologous SCT is feasible, safe and can result in complete remission in a significant proportion of patients with tumour stage mycosis fungoides. Despite a short relapse-free survival, most patients achieved good disease control at the time of relapse.This publication has 21 references indexed in Scilit:
- Detection of a Peripheral Blood T Cell Clone is an Independent Prognostic Marker in Mycosis FungoidesJournal of Investigative Dermatology, 2000
- TrueLeukemia, 1999
- The depletion of T cells from haematopoietic stem cell transplantsRheumatology, 1999
- Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recoveryBone Marrow Transplantation, 1999
- Combination of Etoposide, Idarubicin, Cyclophosphamide, Vincristine, Prednisone and Bleomycin (VICOP-B) in the Treatment of Advanced Cutaneous T-Cell LymphomaDermatology, 1997
- Diagnostic and prognostic significance of clonal T‐cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoidesThe Journal of Pathology, 1993
- Clinicopathologic and Immunologic Features Associated With Transformation of Mycosis Fungoides to Large-Cell LymphomaThe American Journal of Surgical Pathology, 1992
- Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary SyndromeAnnals of Internal Medicine, 1988
- Mycosis Fungoides in the United StatesJAMA, 1988
- Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiologyJAMA, 1988